Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
370K
-
Shares change
-
-644
-
Total reported value, excl. options
-
$1.4M
-
Value change
-
-$2.75K
-
Number of buys
-
2
-
Number of sells
-
-2
-
Price
-
$3.79
Significant Holders of Acurx Pharmaceuticals, Inc. - COM (ACXP) as of Q2 2022
10 filings reported holding ACXP - Acurx Pharmaceuticals, Inc. - COM as of Q2 2022.
Acurx Pharmaceuticals, Inc. - COM (ACXP) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 370K shares
.
Largest 10 shareholders include Draper Asset Management, LLC (266K shares), TD Waterhouse Canada Inc. (30K shares), BlackRock Inc. (16K shares), CASTLE WEALTH MANAGEMENT LLC (13K shares), GEODE CAPITAL MANAGEMENT, LLC (11.5K shares), ADVISOR GROUP HOLDINGS, INC. (11K shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (10.1K shares), Patriot Financial Group Insurance Agency, LLC (9.75K shares), Tower Research Capital LLC (TRC) (1.76K shares), and UBS Group AG (1.04K shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.